AVIEW LCS vs FEops HEARTguide

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft Co.
VS
by FEops

AI Verdict

AVIEW LCS is designed for diagnostic assessment, specifically for lung cancer screening and the quantification of coronary artery calcification from CT scans. In contrast, FEops HEARTguide is a surgical planning tool that uses AI and digital twin technology for predictive simulations to optimize device sizing and positioning for structural heart procedures. While both operate in the broader cardiology AI space, their distinct focus areas make them suitable for different stages of patient care.

Choose AVIEW LCS if…

Choose AVIEW LCS if your primary need is an AI-powered solution for comprehensive lung cancer screening and multi-faceted cardiopulmonary assessment from low-dose CT scans. This tool is ideal for radiology departments seeking automated detection and analysis of lung nodules, emphysema, and coronary artery calcification, streamlining workflows and enhancing diagnostic accuracy for early disease detection and follow-up.

View AVIEW LCS →

Choose FEops HEARTguide if…

Choose FEops HEARTguide if you require advanced pre-operative planning and predictive simulation for complex structural heart interventions. This platform is best suited for cardiologists and cardiothoracic surgeons aiming to optimize device sizing and positioning through patient-specific digital twins and AI-based anatomical measurements, thereby improving procedural outcomes and personalizing care.

View FEops HEARTguide →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AVIEW LCS FEops HEARTguide
Pricing Contact for pricing Unknown
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) Cloud Based platform
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AVIEW LCS FEops HEARTguide
Product Name AVIEW LCS FEops HEARTguide
Company Coreline Soft Co. FEops NV
Tagline AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment Advancing personalized care in structural heart disease through predictive simulations.
Core Clinical Focus AI-powered solution for detection and analysis of lung nodules, COPD, and coronary artery calcification from CT scans. Cloud-based AI and digital twin platform for structural heart procedure planning, optimizing device sizing and positioning.
Primary Medical Specialties Cardiology, Oncology, Pulmonology, Radiology Cardiology, Cardiothoracic Surgery
Key Feature Highlight Automated lung nodule detection and analysis, Lung-RADS classification, Coronary Artery Calcification (CAC) scoring. Predictive simulation technology, AI-based anatomical measurements, Digital twin technology for patient-specific replicas.

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and FEops HEARTguide.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules, offering integrated analysis for lung cancer, COPD, and coronary artery calcification from low-dose CT scans. FEops HEARTguide is a cloud-based AI and digital twin platform focused on structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning.
AVIEW LCS is intended for use across Cardiology, Oncology, Pulmonology, and Radiology specialties. FEops HEARTguide is specifically designed to support Cardiology and Cardiothoracic Surgery.
AVIEW LCS provides automated lung nodule detection and analysis, Lung-RADS classification, nodule volume quantification, emphysema quantification (LAA index), and Coronary Artery Calcification (CAC) scoring. FEops HEARTguide offers AI-based anatomical measurements, semi-automatic identification and measurement of anatomical landmarks, and evaluation of device sizing and positioning pre-operatively.
AVIEW LCS offers integration with PACS/RIS and third-party platforms. FEops HEARTguide features a DICOM interface for CT scan upload.
AVIEW LCS provides comprehensive, automated report generation and automated comparison of nodules in follow-up CT scans. FEops HEARTguide offers an interactive 2D and 3D viewer for evaluating device sizing and positioning.
AI Tool Finder
AI-powered search. Results may not be comprehensive.